Skip to main content

Profile hero

Giuliano Marzi


Capital markets |

Giuliano is able to find accommodating solutions.

Chambers Global, Capital Markets, Italy, 2023

Profile details

About Giuliano Marzi

Giuliano specialises in banking and finance.

His practice is mainly concentrated on a range of Italian domestic and international financing transactions in connection with structured finance, securitisations, asset-based financings and other leveraged transactions.

His experience includes investments and divestments in non-performing loan portfolios by international and domestic banks, as well as debt capital markets transactions.

He speaks English, French, Italian and Romanian.

Recent work

  • Advising a pool of banks, as mandated lead arrangers, bookrunners and lenders on the financing supporting the acquisition by ERG of the Italian hydro assets disposed by E.ON.
  • Advising a major private equity firm, as borrower, on the financing granted by a pool of Italian banks in relation to the acquisition of Suba Seeds and the refinancing of its debt.
  • Advising leading international investors on the purchase of various non-performing loan portfolios originated by Italian and international banks.
  • Advising a major international airline company on the issue of notes due 2020 admitted to trading on the Vienna Third Market.
  • Advising a leading American private equity fund on the financing for the acquisition of various real estate assets located in different European jurisdictions.



  • Pallas Consortium, University of Nijmegen, the Netherlands (LLM in European business law)
  • LUISS ‘Guido Carli’, Rome, Italy (law, JD)

Professional qualifications

  • Admitted to the Italian Bar (avvocato)


  • Securitizations – Legal & Regulatory Issues, Law Journal Press, 2015 The Law of Securitization in Italy

  • Strumenti finanziari e Fiscalità, No.13, 2013, p.61 et seq EMIR – Stato di attuazione del regolamento comunitario in materia di contratti derivati OTC [EMIR – Implementation status of the EC Regulation on OTC derivatives]